Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EUCR NASDAQ:GLAQ NASDAQ:MACU NASDAQ:MOTN NYSE:NBA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEUCREucrates Biomedical Acquisition$10.04$10.08$9.87▼$10.25$42.27M-0.072,287 shs12,700 shsGLAQGlobis Acquisition$9.47$9.86$9.10▼$11.00$142.53M-0.0354,887 shs27,176 shsMACUMallard Acquisition$10.09$9.97$9.66▼$10.48$138.74M-0.0676,784 shs1 shsMOTNMotion Acquisition$10.25$10.12$9.77▼$11.86$147.34MN/A89,698 shs879,900 shsNBANew Beginnings Acquisition$9.98$9.27▼$11.00$1.62MN/A112,648 shs2.76 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEUCREucrates Biomedical Acquisition0.00%0.00%0.00%0.00%0.00%GLAQGlobis Acquisition0.00%0.00%0.00%0.00%0.00%MACUMallard Acquisition0.00%0.00%0.00%0.00%0.00%MOTNMotion Acquisition0.00%0.00%0.00%0.00%0.00%NBANew Beginnings Acquisition0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEUCREucrates Biomedical Acquisition$10.04$10.08$9.87▼$10.25$42.27M-0.072,287 shs12,700 shsGLAQGlobis Acquisition$9.47$9.86$9.10▼$11.00$142.53M-0.0354,887 shs27,176 shsMACUMallard Acquisition$10.09$9.97$9.66▼$10.48$138.74M-0.0676,784 shs1 shsMOTNMotion Acquisition$10.25$10.12$9.77▼$11.86$147.34MN/A89,698 shs879,900 shsNBANew Beginnings Acquisition$9.98$9.27▼$11.00$1.62MN/A112,648 shs2.76 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEUCREucrates Biomedical Acquisition0.00%0.00%0.00%0.00%0.00%GLAQGlobis Acquisition0.00%0.00%0.00%0.00%0.00%MACUMallard Acquisition0.00%0.00%0.00%0.00%0.00%MOTNMotion Acquisition0.00%0.00%0.00%0.00%0.00%NBANew Beginnings Acquisition0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEUCREucrates Biomedical Acquisition 0.00N/AN/AN/AGLAQGlobis Acquisition 0.00N/AN/AN/AMACUMallard Acquisition 0.00N/AN/AN/AMOTNMotion Acquisition 0.00N/AN/AN/ANBANew Beginnings Acquisition 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEUCREucrates Biomedical AcquisitionN/AN/A$0.81 per share12.36($1.25) per shareN/AGLAQGlobis AcquisitionN/AN/AN/AN/A($0.23) per shareN/AMACUMallard AcquisitionN/AN/AN/AN/A($1.32) per shareN/AMOTNMotion AcquisitionN/AN/AN/AN/AN/AN/ANBANew Beginnings AcquisitionN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEUCREucrates Biomedical Acquisition$2.42MN/A0.00∞N/AN/A-62.82%2.95%N/AGLAQGlobis Acquisition-$2.67MN/A0.00∞N/AN/A-197.23%-2.87%N/AMACUMallard Acquisition-$3.06MN/A0.00∞N/AN/AN/AN/AN/AMOTNMotion AcquisitionN/AN/A0.0056.94N/AN/AN/AN/AN/ANBANew Beginnings AcquisitionN/AN/A0.000.00N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEUCREucrates Biomedical AcquisitionN/AN/AN/AN/AN/AGLAQGlobis AcquisitionN/AN/AN/AN/AN/AMACUMallard AcquisitionN/AN/AN/AN/AN/AMOTNMotion AcquisitionN/AN/AN/AN/AN/ANBANew Beginnings AcquisitionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEUCREucrates Biomedical AcquisitionN/A2.032.03GLAQGlobis AcquisitionN/A0.010.01MACUMallard AcquisitionN/A0.670.67MOTNMotion AcquisitionN/AN/AN/ANBANew Beginnings AcquisitionN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEUCREucrates Biomedical Acquisition56.02%GLAQGlobis AcquisitionN/AMACUMallard Acquisition79.30%MOTNMotion Acquisition92.40%NBANew Beginnings Acquisition53.03%Insider OwnershipCompanyInsider OwnershipEUCREucrates Biomedical Acquisition19.50%GLAQGlobis AcquisitionN/AMACUMallard Acquisition20.00%MOTNMotion AcquisitionN/ANBANew Beginnings AcquisitionN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEUCREucrates Biomedical Acquisition44.21 million3.39 millionNot OptionableGLAQGlobis Acquisition115.05 millionN/ANot OptionableMACUMallard Acquisition213.75 million11.00 millionNot OptionableMOTNMotion AcquisitionN/A14.38 millionN/ANot OptionableNBANew Beginnings Acquisition114.38 millionN/ANot OptionableNBA, GLAQ, MOTN, MACU, and EUCR HeadlinesRecent News About These CompaniesESPN circles Fridays for new college football windowSeptember 12 at 4:05 AM | msn.comCan Amen Thompson Finally Address a Critical Weakness To Help the Rockets Win It All?September 3, 2025 | msn.comNets Acquisition of Haywood Highsmith Leaves Rookies Playing Time UncertainAugust 19, 2025 | msn.comJazz new trade acquisition has outperformed Utah in shocking stat since 2020August 6, 2025 | msn.comNBA Free Agency Rumors: New York Knicks predicted to land $50 million Orlando Magic star to boost bench depth and improve title oddsJuly 25, 2025 | msn.com$94 Million NBA Star Traded to Nuggets Shares Immediate ReactionJuly 3, 2025 | msn.comJeanie Buss on the future of the Lakers: "This is not a goodbye, but a new beginning"June 27, 2025 | marca.comMJoe Dumars wastes no time making moves as Pelicans’ new head of basketball operationsJune 27, 2025 | msn.comIs This The Beginning Of A New NBA Era With Pacers vs. Thunder NBA Finals?June 5, 2025 | msn.comKnicks could deal OG Anunoby, acquire $186 million Kings center via blockbuster swapApril 1, 2025 | msn.comThe Pursuit and Challenges of the Post-Duncan Era: The Spurs' New BeginningMarch 15, 2025 | sohu.comSWhy Luka Dončić’s first game against Mavericks was only the beginning of NBA’s new rivalryFebruary 27, 2025 | nytimes.comLakers newly-acquired superstar guard is off to a slow start with new teamFebruary 20, 2025 | msn.comSacramento Kings introduce new players after adding reinforcements at NBA trade deadlineFebruary 8, 2025 | msn.comNBA trade tracker: Every deadline deal as Jimmy Butler, Brandon Ingram, De'Aaron Fox find new homesFebruary 6, 2025 | cbssports.comOperation HOPE Releases 2024 National Impact Report Highlighting Continued Impressive Growth and Improved Client OutcomesFebruary 6, 2025 | businesswire.comNBA trade tracker: Follow every deadline deal as Jimmy Butler, Brandon Ingram find new homesFebruary 6, 2025 | cbssports.comWhen is Luka Doncic coming back from his injury? Latest health report on the Lakers’ new acquisitionFebruary 2, 2025 | en.as.comEDiamond Sports Group, Cavs TV partner, emerges from bankruptcy with new lease on lifeJanuary 6, 2025 | msn.comLakers Must Remain Aggressive After Dorian Finney-Smith Trade amid Latest NBA RumorsDecember 30, 2024 | bleacherreport.comB Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025NIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 20255 High Short-Interest Stocks to Buy Before NovemberBy Thomas Hughes | August 20, 2025As Bitcoin Falls and Ethereum Rallies, Coinbase Stock Comes BackBy Gabriel Osorio-Mazilli | August 25, 2025NBA, GLAQ, MOTN, MACU, and EUCR Company DescriptionsEucrates Biomedical Acquisition NASDAQ:EUCREucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.Globis Acquisition NASDAQ:GLAQGlobis Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Boca Raton, Florida.Mallard Acquisition NASDAQ:MACUMallard Acquisition Corp. does not have significant operations. It focuses on the effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Cornelius, North Carolina.Motion Acquisition NASDAQ:MOTNMotion Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company intends to focus on the vehicle industry, which includes companies that provide transportation software and cloud solutions for fleet management, freight and logistics, and mobile asset management applications. Motion Acquisition Corp. was incorporated in 2020 and is based in New York, New York.New Beginnings Acquisition NYSE:NBANew Beginnings Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Miami, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
